Discover B2B leads for Biotechnology industry
Identify and research relevant prospects for B2B lead generation on Biotechnology sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 62 in our database
Found 496 in our records
HQ: Minneapolis, Minnesota, United States
Medtronic
Medtronic develops healthcare technology solutionsShow more... for various medical conditions.
HQ: Minneapolis, Minnesota, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1949
Number of Exits: 28
Company Type: For Profit
Stock Symbol: NYSE:MDT
Operating Status: Active
42 Emails
0 Phones
Main email format: sarah.smith@medtronic.com (94.4%)
-
Omar Ishrak
CEO
o**r@medtronic.com
-
Markowski
Senior Manager
m*******i@medtronic.com
-
Robert Vigersky
Medical Director
r*************y@medtronic.com
-
Ben Thom
Senior Regional Contract Manager
b******m@medtronic.com
-
Ludmila Larson
Senior Contract & Data Analyst
l************n@medtronic.com
-
Karen Parkhill
EVP & Chief Financial Officer
k************l@medtronic.com
-
Terry Menebroker
Manager Contract Development at Medtronic
t**************r@medtronic.com
-
Jeff Scarborough
Regional Sales Manager, Cardiac and Vascular Group, Western Canada
j**************h@medtronic.com
-
Geoffrey Martha
Chairman & Chief Executive Officer
g*************a@medtronic.com
-
Milo Metcalf
Vice President of Contract Manufacturing
m**********f@medtronic.com
-
Gerard Kilcommins
Vice President Global Operations & General Manager Galway Site
g**************s@medtronic.com
-
Stewart Mccall
Enabling Technologies District Sales Manager
s************l@medtronic.com
-
Diana Murazzo
Principal Contract Analyst
d***********o@medtronic.com
-
Crosby Hull
Associate Sales Representative, Spine
c*********l@medtronic.com
-
Fabiënne Keulers
Clinical Study Assistant CRHF
f**************s@medtronic.com
-
Marc Vanhoutte
Therapy Specialist pain
m************e@medtronic.com
-
Melissa Engelhart
Sr. Director, Global Brand - Corporate Marketing
m***************t@medtronic.com
-
Gisele Osborn
Principal Quality Engineer, Post Market Vigilance
g***********n@medtronic.com
-
Scott Vanderwerf
s**************f@medtronic.com
-
Eric Foster
e*********r@medtronic.com
-
Julie Fischbach
j*************h@medtronic.com
-
Akash Beejawat
a************t@medtronic.com
-
Åsa Grosso
a********o@medtronic.com
-
Sheila Minske
Director of Global Supply Chain Strategy and Innovation at Medtronic
s***********e@medtronic.com
-
Francesca Battistoni
f******************i@medtronic.com
-
Braden Hopps
b**********s@medtronic.com
-
Peter Byron
p*********n@medtronic.com
-
Roy Wilsker
r*********r@medtronic.com
-
Chas Pall
c*******l@medtronic.com
-
Kevin Kelley
Director of Sustainability & Business Development
k**********y@medtronic.com
-
Eoin Keane
e********e@medtronic.com
-
Ben Karel
b*******l@medtronic.com
-
Stephane Moreau
s*************u@medtronic.com
-
Barbara Sandovalabsher
b********************r@medtronic.com
-
Teresita Obra
t***********a@medtronic.com
-
Giacomo Iacomino
g**************o@medtronic.com
-
Raheel Ahmad
r**********d@medtronic.com
-
Alessandro Antico
a***************o@medtronic.com
-
Gal Noiman
Import, Export & Logistics Coordinator
g********n@medtronic.com
-
Unclassified inbox
michelle.r.claypool@medtronic.com
-
Unclassified inbox
RS.MedtronicAcademy@medtronic.com
-
Unclassified inbox
customerservice.portugal@medtronic.com
HQ: Temple City, California, United States
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
HQ: Temple City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
17 Emails
1 Phones
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Lawrence Weiss
l****s@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Alex Witterschein
a**************n@fulgentgenetics.com
-
Erin Heaney
e*****y@fulgentgenetics.com
-
Eric Chen
e******n@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com
HQ: Northbrook, Illinois, United States
Horizon Pharma
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
14 Emails
1 Phones
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
Shvetali Thatte
s*************e@horizontherapeutics.com.If
2**********0
-
Tina Ventura
t**********a@horizontherapeutics.com
-
Lou Scerbo
l*****o@horizontherapeutics.com
-
Maria Tello
m****o@horizontherapeutics.com
-
Randall Schenck
r*************k@horizontherapeutics.com
-
Paul Vanek
p********k@horizontherapeutics.com
-
Anne O'Donnell
a*******l@horizontherapeutics.com
-
Todd Smith
t****h@horizontherapeutics.com
-
James Inglis
j*****s@horizontherapeutics.com
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com
HQ: Los Angeles, California, United States
Kite Pharma
Kite Pharma is a development-stage biotechnology cShow more...ompany designing and developing immune-based therapies to treat cancer indications.
HQ: Los Angeles, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Nov 30, 2023
Founded Date: 2009
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:KITE
Operating Status: Active
Investor Type: Venture Capital
12 Emails
0 Phones
Main email format: ssmith@kitepharma.com (100.0%)
-
Juliati Rahajeng
Manager, Regulatory Writing
j*******g@kitepharma.com
-
Emmanuelle Cunha
Yescarta Product Team Lead
e****a@kitepharma.com
-
Ryan Carrera
Senior Manager of Supply Chain - Enterprise Systems BPO Finance
r******a@kitepharma.com
-
Jose Lanz
Director Project Controls
j***z@kitepharma.com
-
Jorge Jr
Materials Technician
j********z@kitepharma.com
-
Brij Parikh
Sr. Manager, Validation
b*****h@kitepharma.com
-
Saomai Nguyenmau
Senior Manager, External Research Collaboration
s********u@kitepharma.com
-
Khachik Najaryan
Sr. Manager, Supply Chain
k*******n@kitepharma.com
-
Danny Lee
Cell Therapy Specialist II+
d**e@kitepharma.com
-
Jenn Taylor
Senior Talent Acquisition Specialist
j******6@kitepharma.com
-
Lynn Wondergem
IT Business Partner
l********m@kitepharma.com
-
General Inquiries
info@kitepharma.com
HQ: New York, New York, United States
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
HQ: Bothell, Washington, United States
Seagen
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
HQ: Bothell, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@seagen.com (83.3%)
-
Guy Padbury
Senior Vice President, Translational Sciences
g******y@seagen.com
-
Bryce Mansfield
Executive Director, R&D Quality
b********d@seagen.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k*****i@seagen.com
-
Davina Sparks Henderson
Sr Manager. Field Reimbursement
d********n@seagen.com
-
Virginie Oble Bouvet
v***e@seagen.com
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
General Inquiries
contact@seagen.com
HQ: Redwood City, California, United States
Guardant Health
Guardant Health is a precision oncology company thShow more...at uses blood tests, data sets, and analytics to provide treatment to cancer patients.
HQ: Redwood City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 6, 2024
Founded Date: 2012
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:GH
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@guardanthealth.com (100.0%)
-
Amirali Talasaz
Co-founder, President and Chairman
a******z@guardanthealth.com
-
Clancy Smith
Senior Recruiter
c****h@guardanthealth.com
-
Rafael Silva
Account Manager
r****a@guardanthealth.com
-
Soni Shukla
Head of Oncology Product Development- Global
s*****a@guardanthealth.com
-
Meredith Montgomery
Account Executive
m*********y@guardanthealth.com
-
Monique Brausa
Account Executive
m*****a@guardanthealth.com
-
Mehran Entezari
Head Of Information Technology
m@guardanthealth.com
-
Sucharita Nandan
s*****n@guardanthealth.com
-
General Press Inquiries
press@guardanthealth.com
HQ: South Plainfield, New Jersey, United States
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company thShow more...at engages in the discovery, development and commercialization of small-molecule drugs.
HQ: South Plainfield, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 19, 2024
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:PTCT
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@ptcbio.com (66.7%)
-
Peter P. Giannousis
Vice President Technical Operations
p*********s@ptcbio.com
-
Paul Cosenza
Associate Director Global Commercial Learning
p******a@ptcbio.com
-
Lynne Messner
Market Development Manager -- Gene Therapy
l******r@ptcbio.com
-
Brett Billmeyer
Associate Director, U.S. Patient Engagement
b********r@ptcbio.com
-
Tasha Alex
Manager, Clinical Supplies Planning
t***x@ptcbio.com
-
Neha Shah
Associate Director Quality Assurance
n*******h@ptcbio.com
-
Ludovic Baillon
Investment Analyst
l************n@ptcbio.com
-
General Inquiries
info@ptcbio.com
-
Unclassified inbox
Info.Nordic@ptcbio.com
-
Unclassified inbox
pharmacovigilance@ptcbio.com
-
General Inquiries
usmedinfo@ptcbio.com
HQ: Castres-gironde, Aquitaine, France
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
HQ: Castres-gironde, Aquitaine, France
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
HQ: Morrisville, North Carolina, United States
Syneos Health
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
HQ: Morrisville, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Sean Wallace
Clinical Technician
s**********e@syneoshealth.com
-
Elgin C Duckery
District Sales Manager
e***********y@syneoshealth.com
-
Aparna Sree
Talent Acquisition Spec II
a******p@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com
HQ: Hamburg, Hamburg, Germany
Evotec
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
HQ: Hamburg, Hamburg, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah.smith@evotec.com (75.0%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
Alessandro Orsetti
a****************i@evotec.com
-
Alex Jakober
Sr Systems Engineer
a**********r@evotec.com
-
Christopher W.
IT Group Leader Site Services
c***********w@evotec.com
-
General Inquiries
info@evotec.com
HQ: Dublin, Dublin, Ireland
Shire
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
9 Emails
0 Phones
Main email format: ssmith@shire.com (100.0%)
-
Katelyn Mallozzi
Head of Global Planning and Design
k*******i@shire.com
-
Scott Donald
UK Head of Neuroscience
s*****d@shire.com
-
Nirvan Hulangamuwa
Finance Business Partner
n**********a@shire.com
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com
HQ: Cambridge, Massachusetts, United States
Intellia Therapeutics
Intellia Therapeutics is a genome editing company Show more...that develops curative gene-editing treatments.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 22, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NTLA
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@intelliatx.com (100.0%)
-
Eliana Clark
Chief Technical Officer
e**********k@intelliatx.com
-
Samantha Soukamneuth
Associate Director
s******************h@intelliatx.com
-
Mary Margaret McKee
m********e@intelliatx.com
-
Unclassified inbox
medicalinformation@intelliatx.com
-
Unclassified inbox
privacy@intelliatx.com
-
Unclassified inbox
abcdefghij@intelliatx.com
-
Unclassified inbox
lina.li@intelliatx.com
-
General Inquiries
info@intelliatx.com
HQ: Seattle, Washington, United States
CTI BioPharma
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@ctibiopharma.com (100.0%)
-
Chuck Bianco
c*****o@ctibiopharma.com
-
Natalie Jaynes Brunner
Key Account Manager
n******r@ctibiopharma.com
-
patrizia angiuli
p******i@ctibiopharma.com
-
General Inquiries
medinfo@ctibiopharma.com
HQ: Maple Grove, Minnesota, United States
Inspire Medical Systems
Inspire Medical Systems develops implantable theraShow more...peutic devices for the treatment of obstructive sleep apnea.
HQ: Maple Grove, Minnesota, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 20, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: NYSE:INSP
Operating Status: Active
4 Emails
0 Phones
Main email format: sarahsmith@inspiresleep.com (100.0%)
-
Tim Herbert
President & CEO
t********t@inspiresleep.com
-
Mitchell Nelson
Territory Manager
m************n@inspiresleep.com
-
Ezgi Yagci
e*******i@inspiresleep.com
-
General Inquiries
contact@inspiresleep.com
HQ: Silver Spring, Maryland, United States
United Therapeutics
United Therapeutics Corporation is a biotechnologyShow more... company focused on the development and commercialization of unique products.
HQ: Silver Spring, Maryland, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 28, 2024
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:UTHR
Operating Status: Active
3 Emails
0 Phones
Main email format: ssmith@unither.com (100.0%)
-
Heidi Bell
Medical Director, Medical Monitoring
h***l@unither.com
-
Nicole Wilkerson
n********n@unither.com
-
Gil PhD
Senior Vice President and Chief Medical Officer
ggolden@unither.com
-
General Inquiries
info@unither.com
HQ: Emeryville, California, United States
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled releaseShow more... combination therapeutics for infectious diseases and central nervous system disorders.
HQ: Emeryville, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Nov 24, 2021
Founded Date: 2000
Company Type: For Profit
Stock Symbol: NASDAQ:ADMS
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@adamaspharma.com (100.0%)
-
Mary Jean Stempien
VP, Clinical Research
m**********n@adamaspharma.com
-
George Gindoyan
Vice President Information Technology
g*******n@adamaspharma.com
-
David Chernoff
Chief Medical Officer
-
Vijay Shreedhar
Chief Commercial Officer
-
Investor Relations
ir@adamaspharma.com
-
General Inquiries
info@adamaspharma.com
HQ: South San Francisco, California, United States
Amunix
Amunix is a biopharmaceutical company intended to Show more...discover, design, and develop novel biologics, protein, and peptide therapeutics.
HQ: South San Francisco, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Series B
Last Investment Activity: Feb 9, 2022
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
Main email format: ssmith@amunix.com (100.0%)
-
Volker Schellenberger
Co-Founder, President, and CTO
v*************r@amunix.com
-
Shanrong Zhao
Vice President & Head of Bioinformatics, Data Analytics and Library Design
s***o@amunix.com
-
Walter H. Moos
Board Member
-
Harold E. Selick
Board Member
-
Maninder Hora
Chief Technical Operations Officer
-
Unclassified inbox
bd@amunix.com
HQ: Cambridge, Massachusetts, United States
Biogen
Biogen is an American biotechnology company that pShow more...rovides therapeutics for neurological, autoimmune, and rare diseases.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Sep 1, 2023
Founded Date: 1978
Number of Exits: 17
Company Type: For Profit
Stock Symbol: NASDAQ:BIIB
Operating Status: Active
Investor Type: Venture Capital
2 Emails
0 Phones
Main email format: sarah.smith@biogen.com (100.0%)
-
Sally John
VP Translational Biology
s********n@biogen.com
-
Leticia Brewington
Principal Business Analyst
leticia.brewington@biogen.com
-
Deborah Glasser
Associate Director - BG12 HCP Marketing
-
Jaren Landen
Early Alzheimer's Disease Head
-
David Kolwyck
Director Manufacturing Science - Raw Materials
-
Elodie Cramer
Associate Director and Strategic Sourcing
-
Yizhou Zhou
Head of Cell Line Technology, Gene Therapy Development
-
Georgia Mitsi
GM Mental Health & VR solutions
-
Firoz Antia
Executive Director, Head of Oligonucleotide Development
-
Baohong Zhang
Head of Genome Informatics
-
General Inquiries
info@biogen.com
HQ: Illkirch, Alsace, France
Domain Therapeutics
Domain Therapeutics develops small molecules targeShow more...ting G-coupled protein receptors.
HQ: Illkirch, Alsace, France
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Grant
Last Investment Activity: Mar 12, 2024
Founded Date: 2001
Company Type: For Profit
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@domaintherapeutics.com (100.0%)
-
Arturo Mancini
a******i@domaintherapeutics.com
-
Sean A. MacDonald
Chief Business Officer
s********d@domaintherapeutics.com
-
Pascal Neuville
Chief Executive Officer
-
Xavier Leroy
Chief Technology Officer
-
Stanislas leonard Malmezat
Chief Financial Officer
-
Stephan Schann
Chief Scientific Officer
-
Marjorie Sidhoum
Director of Business Operations
-
Admin Team
admin@domaintherapeutics.com
-
General Inquiries
contact@domaintherapeutics.com
HQ: Prague, Hlavni mesto Praha, Czech Republic
Sotio
Sotio is a biotechnology company developing a new Show more...immunotherapy based on activated dendritic cells for the treatment of cancer.
HQ: Prague, Hlavni mesto Praha, Czech Republic
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: Oct 31, 2023
Founded Date: 2010
Company Type: For Profit
Operating Status: Active
5 Emails
0 Phones
Main email format: smith@sotio.com (100.0%)
-
Robyn Hunter
Chief Financial Officer
h****r@sotio.com
-
Gordana Rusnov Zafranovic
g*********c@sotio.com
-
Jens Hennecke
Chief Business Officer
-
Richard Sachse
Chief Medical Officer
-
Radek Spisek
Chief Executive Officer and Founder
-
Admin Team
admin@sotio.com
-
Legal Department
legal@sotio.com
-
Media Relations
media@sotio.com
HQ: Lebanon, New Hampshire, United States
Adimab
Adimab is an antibody discovery and optimization pShow more...latform, developing full-length human Immunoglobulin Gs.
HQ: Lebanon, New Hampshire, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: Jan 10, 2024
Founded Date: May 1, 2007
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
-
Amber Davis-Hanna
Principal Research Associate II
a*********a@adimab.com
-
Guy Van Meter
g*********r@adimab.com
-
K. Dane Wittrup
Co-founder, Chair of the SAB
-
Tillman Gerngross
Founder & Executive Chairman
-
Philip Chase
CEO
-
Max Vasquez
VP Computational Biology
-
Eric Krauland
President and Chief Scientific Officer
-
Piotr Bobrowicz
Director, Open Innovation
-
Errik Anderson
Co-Founder
-
General Inquiries
info@adimab.com
HQ: Cheshire, Connecticut, United States
Alexion Pharmaceuticals
Alexion Pharmaceuticals is a biopharmaceutical comShow more...pany that engages in the development and commercialization of mid-to-late-stage therapies.
HQ: Cheshire, Connecticut, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Acquired by: AstraZeneca
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Apr 15, 2024
Founded Date: 1992
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ALXN
Operating Status: Active
3 Emails
0 Phones
Main email format: sarah@alexion.com (50.0%)
-
Danielle Desrosiers
Associate Director, Global Talent Acquisition Lead, Corporate Functions
d*****************s@alexion.com
-
Don Owens
Customer Success Manager
d*n@alexion.com
-
Leonard Bell
Founder
-
Carsten Thiel
Executive Vice President, Chief Commercial Officer
-
David Chen
CMC Program Leader
-
Imran Shakur
Director, IRT and Technology Lead
-
William Keller
Director
-
Frank Wright
Senior Vice President, API President
-
Andreas Rummelt
Director
-
Uzair Qadeer
Chief Diversity Officer
-
Unclassified inbox
AdverseEventReporting@alxn.com
HQ: San Diego, California, United States
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical compaShow more...ny that develops therapies for people with rare endocrine diseases.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: 2008
Company Type: For Profit
Stock Symbol: NASDAQ:CRNX
Operating Status: Active
6 Emails
0 Phones
Main email format: ssmith@crinetics.com (100.0%)
-
Scott Struthers
Co-Founder and CEO
s********s@crinetics.com
-
Yun-Fei Zhu
Co-Founder & Vice President, Chemistry
-
Stephen F. Betz
Vice President, Biology
-
Max Bronstein
Executive Director of Government Affairs and Patient Advocacy
-
Dana Pizzuti
Chief Development Officer
-
Alan S. Krasner
Chief Medical Officer
-
Chris Robillard
Chief Business Officer
-
Jeff Knight
COO
-
General Inquiries
info@crinetics.com
-
General Inquiries
hello@crinetics.com
-
Admin Team
admin@crinetics.com
-
Customer Service
support@crinetics.com
-
Sales Department
sales@crinetics.com
HQ: Martinsried, Bayern, Germany
MediGene
MediGene is a company that specializes in biotechnShow more...ology specifically in the treatment of cancer.
HQ: Martinsried, Bayern, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Mar 4, 2024
Founded Date: 1994
Company Type: For Profit
Stock Symbol: ETR:MDG1
Operating Status: Active
3 Emails
0 Phones
Main email format: sarah.smith@medigene.com (100.0%)
-
Pamela Keck
Vice President of Investor Relations and Corporate Communications
p*********k@medigene.com
-
James Noble
Non Executive Director
-
Gerrit Brandt
Director Accounting and Controlling
-
Dolores Schendel
Chief Scientific Officer and Managing Director
-
Investor Relations
investor@medigene.com
-
Unclassified inbox
medigene@medigene.com
HQ: Plymouth Meeting, Pennsylvania, United States
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing tShow more...o market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
HQ: Plymouth Meeting, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 23, 2024
Founded Date: 1979
Company Type: For Profit
Stock Symbol: NASDAQ:INO
Operating Status: Active
3 Emails
0 Phones
Main email format: sarah@inovio.com (100.0%)
-
Jennifer Laux
Vice President, Marketing
j******r@inovio.com
-
Laurent Humeau
Chief Scientific Officer,Executive Vice President of Research, Engineering and Clinical Developments
-
Peter Kies
Chief Financial Officer
-
Michael Sumner
Chief Medical Officer
-
Jacqueline Shea
Chief Executive Officer
-
Paul Fisher
Director of Bioengineering
-
Shawn Bridy
Senior Vice President, Business Development
-
Unclassified inbox
jennie.willson@inovio.com
-
Unclassified inbox
ino@inovio.com
HQ: Copenhagen, Hovedstaden, Denmark
Orphazyme
Orphazyme develops innovative new therapies for thShow more...e treatment of a family of serious genetic disorders called lysosomal storage diseases.
HQ: Copenhagen, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Feb 21, 2024
Founded Date: 2009
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ORPH
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah@orphazyme.com (100.0%)
-
Shilpa Chatlani
Senior Director, Medical Affairs
s****a@orphazyme.com
-
Anders Hinsby
Chief Executive Officer
-
Thomas Kirkegaard Jensen
Chief Scientific Officer
-
Paul Merrigan
Chief Commercial Officer
-
Claus Sundgreen
Medical Director
-
Thomas Blaettler
Chief Medical Officer
-
Christophe Bourdon
Chief Executive Officer
-
Tim Kanter
Vice President Market Access, Trade and Pricing
-
Anders Fink Vadsholt
Chief Financial Officer
-
General Inquiries
usmedinfo@orphazyme.com
-
General Inquiries
contact@orphazyme.com
-
Unclassified inbox
last_initial@orphazyme.com
-
Unclassified inbox
tlg@orphazyme.com
HQ: San Francisco, California, United States
Alector
Alector is combining state-of-the-art antibody tecShow more...hnology and recent discoveries in neuroimmunology and human genetics to develop novel.
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 28, 2024
Founded Date: 2013
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ALEC
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@alector.com (100.0%)
-
Arnon Rosenthal
Founder, President & Chief Executive Officer
a*************l@alector.com
-
Robert Paul
Chief Medical Officer
-
Virginia DeJesus-Rueff
VP of Portfolio and Program Management
-
Marina Roell
Principal Scientist
-
Charles Wolfus
VP of Technology and Digital Health
-
Herve Rhinn
Head of Target Discovery and Genomics
-
Kristina Vlaovic
Vice President of Regulatory Affairs & Pharmacovigilance
-
Calvin Yu
VP Finance
-
General Inquiries
info@alector.com
-
Customer Service
support@alector.com
-
General Inquiries
help@alector.com
HQ: Waltham, Massachusetts, United States
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinShow more...ase inhibitor treatments.
HQ: Waltham, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:DCPH
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@deciphera.com (100.0%)
-
Philippe Teboul
p*****l@deciphera.com
-
Steven L. Hoerter
President and CEO
-
Steve Ruddy
CTO
-
Chris Morl
CBO
-
Matthew L. Sherman
EVP & CMO
-
Daniel Flynn
Founder and Chief Scientific Officer
-
Tucker P. Kelly
EVP & Chief Financial Officer
-
General Inquiries
info@deciphera.com
-
Unclassified inbox
lkiniklis@deciphera.com
-
Unclassified inbox
medicalinformation@deciphera.com
HQ: Germantown, Maryland, United States
Precigen
Precigen is a life sciences company researching anShow more...d developing bio-therapeutic control systems to minimize toxicity.
HQ: Germantown, Maryland, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Mar 29, 2024
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:PGEN
Operating Status: Active
2 Emails
0 Phones
Main email format: ssmith@precigen.com (100.0%)
-
Don Lehr
Chief Legal Officer
d***r@precigen.com
-
Rutul R. Shah
Chief Operating Officer
-
Douglas E. Brough
Senior Vice President & Head of Research
-
Thomas D. Reed
Founder & Chief Science Officer, Board of Directors
-
Hadyn Parry
Vice President
-
Jack Bobo
Chief Communications Officer
-
Jeffrey T. Perez
Senior Vice President, Intellectual Property Affairs
-
Darryl Webster
Senior Vice President, Intellectual Property
-
Randal J. Kirk
CEO and Chairman
-
Unclassified inbox
swright@intrexon.com
HQ: Austin, Texas, United States
Lung Therapeutics
Lung Therapeutics provides innovative treatments fShow more...or underserved, life-threatening lung conditions.
HQ: Austin, Texas, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 11-50
Rounds: Series C
Last Investment Activity: Nov 1, 2023
Founded Date: 2013
Company Type: For Profit
Operating Status: Active
2 Emails
0 Phones
Main email format: sarahsmith@lungtx.com (100.0%)
-
Matt Karpen
Vice President of CMC
m********n@lungtx.com
-
Charles Garner
Chief Financial Officer
-
Andrew Mazar
Founder
-
Sharon Morriss
SVP, Clinical Development
-
General Inquiries
info@lungtx.com
HQ: Wadenswil, Zurich, Switzerland
Numab
Numab is a biotechnology company that offers antibShow more...ody-based therapeutics for the treatment of severe diseases.
HQ: Wadenswil, Zurich, Switzerland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Series C
Last Investment Activity: Feb 13, 2024
Founded Date: 2011
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
4 Emails
1 Phones
Main email format: s.smith@numab.com (100.0%)
-
David Urech
CSO, and Co-CEO, Founder
d*****h@numab.com
T***********************************************************************************m
-
Oliver Middendorp
CBO, Co-CEO, and Co-Founder
-
Peter Lichtlen
CMO and Co-Founder
-
Tea Gunde
Head of Pharmacology
-
Sebastian Meyer
Chief Operating Officer
-
Roland Helfenstein
Chief Financial Officer
-
General Inquiries
info@numab.com
-
Admin Team
admin@numab.com
-
Legal Department
legal@numab.com
HQ: London, England, United Kingdom
Silence Therapeutics
Silence Therapeutics is a drug development companyShow more... with a proprietary genetic medicine platform.
HQ: London, England, United Kingdom
Specialized In: Biotechnology, Healthcare & Medical, Technology & Software, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Mar 13, 2024
Founded Date: 1999
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:SLN
Operating Status: Active
4 Emails
1 Phones
Main email format: s.smith@silence-therapeutics.com (100.0%)
-
Rhonda Hellums
Chief Financial Officer
r*******s@silence-therapeutics.com
-
Dmitry Samarsky
Chief Scientific Officer
-
Steve Romano
Chief Medical Officer and Head of Research and Development,Non Executive Director
-
Craig Tooman
President and Chief Executive Officer
-
John Paul Gabriel
Chief Technical Operations Officer and Senior Vice President
-
Adrien Weingärtner
Group Leader Drug Delivery
-
John Strafford
SVP, Head of Business Development, Alliance Management and New Product Development
-
Stephen Parker
Director
-
General Inquiries
info@silence-therapeutics.com
-
Investor Relations
IR@silence-therapeutics.com
-
Unclassified inbox
a.mortazavi@silence-therapeutics.com
HQ: Oxford, Oxfordshire, United Kingdom
Vaccitech
Vaccitech is creating novel vaccines that elicit sShow more...trong responses from helper and cytotoxic T-cells.
HQ: Oxford, Oxfordshire, United Kingdom
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Series B
Last Investment Activity: Nov 6, 2023
Founded Date: 2016
Company Type: For Profit
Stock Symbol: NASDAQ:VACC
Operating Status: Active
6 Emails
1 Phones
Main email format: sarah.smith@vaccitech.co.uk (100.0%)
-
Meg Marshall
CMO
m**********l@vaccitech.co.uk
T*******************************************************************k
-
Sarah Gilbert
Co-Founder & Professor of Vaccinology
-
Georgy Egorov
CFO
-
Graham Griffiths
Chief Business Officer
-
Nadege Pelletier
Chief Scientific Officer
-
Thomas Evans
consultant
-
Chris Ellis
Chief Operating Officer
-
Malkit Sami
Associate Director
-
Investor Relations
ir@vaccitech.co.uk
-
Enquiries
enquiries@vaccitech.co.uk
-
Unclassified inbox
henry.hodge@vaccitech.co.uk
-
Unclassified inbox
karim.saleh@vaccitech.co.uk
-
General Inquiries
info@vaccitech.co.uk
HQ: San Diego, California, United States
Vividion Therapeutics
Vividion is a developer of a novel drug discovery Show more...platform designed to offer transformative treatments to patients with serious illnesses.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Series C
Last Investment Activity: Feb 7, 2024
Founded Date: 2013
Company Type: For Profit
Operating Status: Active
6 Emails
0 Phones
Main email format: sarah@vividion.com (100.0%)
-
Diego Miralles
CEO
d***o@vividion.com
-
Shawn Rose
Chief Development Officer (CDO), Immunology
-
Benjamin Cravatt
Founder
-
Jean Bemis
Senior Vice President of Operations and Alliances,Head of Alliance Management
-
Jin-Quan Yu
Founder
-
Patricia Allen
Chief Financial Officer
-
Phil Baran
Founder
-
Admin Team
admin@vividion.com
-
Customer Service
support@vividion.com
-
General Inquiries
help@vividion.com
-
Legal Department
legal@vividion.com
-
Unclassified inbox
information@vividion.com
HQ: Monrovia, California, United States
Xencor
Xencor develops superior monoclonal antibody theraShow more...peutics to treat autoimmune disorders, asthma, allergic diseases and cancer.
HQ: Monrovia, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 28, 2024
Founded Date: 1997
Company Type: For Profit
Stock Symbol: NASDAQ:XNCR
Operating Status: Active
2 Emails
0 Phones
Main email format: sarah.smith@xencor.com (100.0%)
-
John Kuch
Senior Vice President & Chief Scientific Officer
j*******h@xencor.com
-
Bassil Dahiyat
CEO
-
John Desjarlais
Vice President, Research,Chief Scientific Officer
-
Dane Leone
SVP of Corporate Strategy
-
David Szymkowski
Vice President of Preclinical Operations
-
Nancy Valente
Executive Vice President & Chief Development Officer
-
General Inquiries
info@xencor.com
HQ: Paris, Ile-de-France, France
HRA Pharma
HRA Pharma develops and sells reproductive health Show more...drugs, devices, and services to patients
HQ: Paris, Ile-de-France, France
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Private Equity
Last Investment Activity: Jul 10, 2024
Founded Date: 1996
Company Type: For Profit
Operating Status: Active
2 Emails
0 Phones
Main email format: s.smith@hra-pharma.com (100.0%)
-
Francois Durin
Licensing & Alliance Management Director
f*****n@hra-pharma.com
-
Martyn Hilton
Chief Global Commercial Officer
-
David Wright
Chief Executive Officer
-
Geoff Allan
CFO
-
Paul Carter
Chief Scientific Officer
-
Sophie Lacourrège
Chief Human Resources & Communication Officer
-
Florian Battung
Chief Corporate Development & Strategy Officer
-
Unclassified inbox
careers@hra-pharma.com
HQ: London, England, United Kingdom
NetScientific PLC
Investment and commercialisation group with an intShow more...ernational portfolio of innovative life science, sustainability and technology companies.
HQ: London, England, United Kingdom
Specialized In: Biotechnology, Medical Devices, Robotics, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Non-equity Assistance
Founded Date: 2007
Number of Exits: 2
Company Type: For Profit
Stock Symbol: LSE:NSCI
Operating Status: Active
Investor Type: Venture Capital
2 Emails
0 Phones
Main email format: smith@netscientific.net (100.0%)
-
Ilian Iliev
Managing Director
i***v@netscientific.net
-
Dr Ilian Iliev
Chief Executive Officer
-
General Inquiries
info@netscientific.net
HQ: San Francisco, California, United States
Trellis Bioscience
Trellis Bioscience is a therapeutic antibody compaShow more...ny developing treatments for infectious diseases and oncology indications.
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Grant
Last Investment Activity: Mar 25, 2024
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@trellisbio.com (100.0%)
-
Stefan Ryser
President & CEO
s****r@trellisbio.com
-
Stote Ellsworth
Chief Technology Officer
-
Lawrence Kauvar
Founder & Senior Vice President
-
Anton Leighton
Chief Medical Officer
-
Unclassified inbox
mmoncada@trellisbio.com
-
General Inquiries
info@trellisbio.com
-
Unclassified inbox
sryser@trellisbio.com
HQ: London, England, United Kingdom
NetScientific PLC
Investment and commercialisation group with an intShow more...ernational portfolio of innovative life science, sustainability and technology companies.
HQ: London, England, United Kingdom
Specialized In: Biotechnology, Medical Devices, Robotics, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Non-equity Assistance
Last Investment Activity: May 28, 2024
Founded Date: 2007
Number of Exits: 2
Company Type: For Profit
Stock Symbol: LSE:NSCI
Operating Status: Active
Investor Type: Venture Capital
2 Emails
0 Phones
Main email format: smith@netscientific.net (100.0%)
-
Ilian Iliev
Managing Director
i***v@netscientific.net
-
Dr Ilian Iliev
Chief Executive Officer
-
General Inquiries
info@netscientific.net
HQ: Maryland, Louisiana, United States
MedImmune
MedImmune develops medicines for unmet medical neeShow more...ds worldwide.
HQ: Maryland, Louisiana, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Acquired by: AstraZeneca
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Aug 30, 2023
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
4 Emails
0 Phones
Main email format: sarahs@medimmune.com (100.0%)
-
Venkat Raghavan
v*****r@medimmune.com
-
Rakesh Dixit
Vice President, R & D, Global Head, Biologics Safety Assessment
-
Ed Mathers
Executive Vice President, Corporate Development and Venture
-
Frank J. Malinoski
Team Member
-
James Brown
Director, IT Relationship Management, R&D
-
Admin Team
admin@medimmune.com
-
Customer Service
support@medimmune.com
-
Sales Department
sales@medimmune.com
HQ: Maryland, Louisiana, United States
MedImmune
MedImmune develops medicines for unmet medical neeShow more...ds worldwide.
HQ: Maryland, Louisiana, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Acquired by: AstraZeneca
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Aug 30, 2023
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
4 Emails
0 Phones
Main email format: sarahs@medimmune.com (100.0%)
-
Venkat Raghavan
v*****r@medimmune.com
-
Admin Team
admin@medimmune.com
-
Customer Service
support@medimmune.com
-
Sales Department
sales@medimmune.com
HQ: San Diego, California, United States
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a neuro-biotechnology coShow more...mpany developing treatments for neuro-based disorders.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Aug 4, 2023
Founded Date: 2006
Company Type: For Profit
Stock Symbol: NASDAQ:ADMP
Operating Status: Active
1 Emails
0 Phones
-
Dennis J. Carlo
Founder & CEO
-
David C. Benedicto
Chief Financial Officer
-
General Inquiries
info@adamispharma.com
HQ: Seattle, Washington, United States
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, devShow more...elops immunotherapies for the treatment of cancer.
HQ: Seattle, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 251-500
Rounds: Series B
Last Investment Activity: Jun 21, 2023
Founded Date: 2013
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:JUNO
Operating Status: Active
1 Emails
0 Phones
-
Lawrence Corey
Co-Founder
-
Hans Bishop
Co-Founder & CEO
-
Cynthia Elkins
EVP & CIO
-
Hyam Levitsky
Executive Vice President Research, Chief Scientific Officer
-
Isabelle Rivière
Scientific & Co-Founder
-
Michel Sadelain
Scientific Co-Founder
-
Steve Shamah
Head Of Scientific Operation
-
Bill Donahue
Senior Director, Head of Sequencing
-
General Inquiries
Info@junotherapeutics.com
HQ: Beijing, Beijing, China
Sino Biological
Sino Biological is a specialist provider of proteiShow more...n, antibody and gene products.
HQ: Beijing, Beijing, China
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Venture - Series Unknown
Last Investment Activity: Mar 14, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: SZSE:301047
Operating Status: Active
1 Emails
0 Phones
-
Liangzhi Xie
President and CEO
-
Rob Burgess
Chief Business Officer
-
Yang Wang
President
-
Unclassified inbox
Order@sinobiological.com
HQ: Malvern, Pennsylvania, United States
Cephalon
Cephalon is a global biopharmaceutical company dedShow more...icated to discovering, developing and bringing to market medications to improve the
HQ: Malvern, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Last Investment Activity: Oct 19, 2023
Founded Date: 1987
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CEPH
Operating Status: Closed
Investor Type: Venture Capital
1 Emails
0 Phones
-
Frank Baldino, Jr.
Chairman & CEO
-
Piyush Patel
Director
-
Unclassified inbox
orporatecommunications@cephalon.com
HQ: Gilbert, Arizona, United States
Heliae
Heliae is a platform technology company producing Show more...high-value products from algae by using sunlight and low-cost carbon feedstocks.
HQ: Gilbert, Arizona, United States
Specialized In: Biotechnology, Healthcare & Medical, Nutrition, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Venture - Series Unknown
Last Investment Activity: Feb 28, 2020
Founded Date: 2008
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
-
Frank Mars
Co-Founder and Chairman
-
Daniel Simons
President & Chief Executive Officer, Board Member
-
General Inquiries
info@heliae.com
-
Sales Department
sales@heliae.com
-
General Inquiries
info@Heliae.com
HQ: Houston, Texas, United States
ImmunoMet Therapeutics
ImmunoMet Therapeutics is a biopharmaceutical compShow more...any that develops and commercializes oncology products for cancer patients.
HQ: Houston, Texas, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Series B
Last Investment Activity: Jul 26, 2021
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Edward Garmey
Consultant CMO
-
Sungwuk Kim
CEO
-
Revati Shreeniwas
Chief Medical Officer
-
General Inquiries
info@immunomet.com
HQ: Ra'anana, HaMerkaz, Israel
InterCure
InterCure is a medical device company focused on rShow more...espiratory treatment that has developed and patented a technology platform.
HQ: Ra'anana, HaMerkaz, Israel
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: May 2, 2024
Founded Date: Jan 1, 1994
Company Type: For Profit
Stock Symbol: TLV:INCR
Operating Status: Active
HQ: Cambridge, Massachusetts, United States
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegeShow more...nerative diseases.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Series A
Last Investment Activity: Oct 8, 2020
Founded Date: 2011
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Edmund Sybertz
Founder
-
Joseph Mazzulli
Scientific Founder
-
Henri Termeer
Founder
-
Dimitri Krainc
Principal Founding Scientist
-
Mark Carthy
Investor
-
General Inquiries
info@lysosomaltx.com
HQ: Kahoku, Miyagi, Japan
Medinet Co
Cancer immuno-cell therapy is an advanced medical practice.
HQ: Kahoku, Miyagi, Japan
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Sep 29, 2015
Founded Date: 1995
Company Type: For Profit
Stock Symbol: TYO:2370
Operating Status: Active
Investor Type: Corporate Venture Capital
1 Emails
0 Phones
-
Yoshiji Kimura
President and Chief Executive Officer
-
Kohji Egawa
Scientific Founder
-
General Inquiries
info@medinet-inc.co.jp
HQ: Berlin, Berlin, Germany
N1
N1 is a digital biomarker platform for (bio)pharmaShow more...ceutical drug research & development.
HQ: Berlin, Berlin, Germany
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Last Investment Activity: May 29, 2021
Founded Date: 2018
Company Type: For Profit
Operating Status: Active
HQ: Cambridge, Cambridgeshire, United Kingdom
Phico Therapeutics
Phico Therapeutics is a developer of novel platforShow more...m technology designed to overcome antibacterial resistance.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Venture - Series Unknown
Last Investment Activity: Feb 1, 2022
Founded Date: 2000
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
-
Heather Fairhead
Founder & CEO
-
Katy Pitts
Facility manager and senior R&D scientist
-
James Cass
Manager of research and development
-
Anthony Martin
Chairman & Non Executive Director
-
General Inquiries
info@phicotx.co.uk
-
Admin Team
admin@phicotx.co.uk
-
General Inquiries
info@phicotherapeutics.co.uk
HQ: Vancouver, British Columbia, Canada
Novelion Therapeutics
Novelion Therapeutics Inc, formerly QLT Inc., is aShow more... Canada-based biopharmaceutical company
HQ: Vancouver, British Columbia, Canada
Specialized In: Pharmaceuticals, Biotechnology, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Aug 25, 2021
Founded Date: 1981
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NVLN
Operating Status: Active
1 Emails
0 Phones
-
Robert L. Butchofsky
President & CEO
-
Cameron R. Nelson
CFO
-
Investor Relations
ir@qltinc.com
HQ: Beijing, Beijing, China
Sinovac Biotech
Sinovac Biotech Ltd. is a China-based biopharmaceuShow more...tical company that focuses on research, development, manufacturing and commercialization
HQ: Beijing, Beijing, China
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Delisted
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Apr 26, 2024
Founded Date: 2001
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SVA
Operating Status: Active
1 Emails
0 Phones
-
Weidong Yin
Founder & CEO
-
Nan Wang
Vice President, Business Development
-
Unclassified inbox
sinovac@sinovac.com
HQ: Beerse, Antwerpen, Belgium
Janssen Belgium
Janssen Belgium is a pharmaceutical company providShow more...ing medicines for an array of health concerns in several therapeutic areas.
HQ: Beerse, Antwerpen, Belgium
Specialized In: Biotechnology, Healthcare & Medical, Web Development & Design, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Feb 26, 2021
Founded Date: 1953
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Paul Janssen
Founder
-
Iqbal Grewal
Global Head of Immunotherapeutics
-
Maarten Timmers
Head of Clinical Scientists, Experimental Medicine - Neuroscience
-
Suzanne Blaug
Head of Janssen Alzheimer Immunotherapy Research & Development
-
Jennifer Hirsch
Head of Strategy & Innovation for Project Management Organization
-
Conor Kane
Senior Director, Janssen Clinical Innovation
-
Johannes Hermann
Director, Machine Learning and Advanced Algorithms, Data Sciences IT
-
Guy Nuyts
Senior Director Global Pricing Analytics and Innovation
-
General Inquiries
info@janssen.com
HQ: Beerse, Antwerpen, Belgium
Janssen Belgium
Janssen Belgium is a pharmaceutical company providShow more...ing medicines for an array of health concerns in several therapeutic areas.
HQ: Beerse, Antwerpen, Belgium
Specialized In: Biotechnology, Healthcare & Medical, Web Development & Design, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Feb 26, 2021
Founded Date: 1953
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
HQ: Paris, Ile-de-France, France
Neovacs
Neovacs, a biotech company, develops several theraShow more...peutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.
HQ: Paris, Ile-de-France, France
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Debt
Last Investment Activity: Jun 17, 2024
Founded Date: 1993
Number of Exits: 1
Company Type: For Profit
Stock Symbol: EPA:ALNEV
Operating Status: Active
1 Emails
0 Phones
-
Miguel Sieler
Chief Executive Officer
-
Vincent Serra
Chief Scientific Officer
-
Daniel Zagury
Founder
-
Charlène Masson
Corporate Communication Director
-
General Inquiries
contact@neovacs.com
HQ: Morrisville, North Carolina, United States
Envisia Therapeutics
Envisia Therapeutics is a biotechnology company foShow more...cused on the research and development of novel ocular therapies.
HQ: Morrisville, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 11-50
Rounds: Series A
Last Investment Activity: Feb 3, 2017
Founded Date: 2013
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Frank J. Malinoski
CMO
-
General Inquiries
info@envisiatherapeutics.com
HQ: Wilmington, North Carolina, United States
PPD clinical research business of Thermo Fisher Scientific
The PPD clinical research business of Thermo FisheShow more...r Scientific offers CRO services, including clinical development and analytical solutions.
HQ: Wilmington, North Carolina, United States
Specialized In: Biotechnology, Coaching & Consulting, Healthcare & Medical, Medical Devices, Pharmaceuticals, Hospitals & Clinics
Acquired by: Thermo Fisher Scientific
Business Type: Delisted
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Apr 24, 2024
Founded Date: 1985
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:PPD
Operating Status: Active
1 Emails
0 Phones
-
Kimberly Kasprowicz
Sr. Clinical Team Manager
-
Mark Corrigan
Associate Group Leader
-
Brent Reed
Director of IT
-
Duu-Gong Wu
Senior Director, Regulatory and Technical Advisors, Global Regulatory Affairs,
-
Andy Strayer
Vice President
-
Peter Wyld
Vice President, Onocology and Haematology Global Product Development
-
Ronald (Ron) Garrow
Executive Vice President, Chief Human Resources Officer
-
Claire Nickols
Director, Project Oversight, Haematology & Oncology, Global Project Management
-
Unclassified inbox
dpo.sm@ppd.com
HQ: Clermont-ferrand, Auvergne, France
Laboratoires Théa
Laboratoires Thea is an independent pharmaceuticalShow more... company specialized in research,development and commercialization of eyecare products.
HQ: Clermont-ferrand, Auvergne, France
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 501-1000
Last Investment Activity: Jan 31, 2024
Founded Date: 1993
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Fabrice Mercier
Alliance Manager
-
Susan Benton
President, USA
-
Henri Chibret
Founder
-
Marketing Team
globalmarketing@laboratoires-thea.fr
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.